The inhaled formulation is being assessed for COVID-19 patients in the outpatient setting

The benefit outweighs the risks for asthma and COPD patients during the pandemic, they say

Regulators rejected accelerated approval as Roche’s combination for the same patient population made it over the line first

The fines are in addition to £8 million secured for the NHS last year as part of the […]

A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in […]

Updated Date: Wed, 01 Jul 2020 00:00:00 EDT

Updated Date: Wed, 01 Jul 2020 00:00:00 EDT

Updated Date: Wed, 01 Jul 2020 00:00:00 EDT

Updated Date: Wed, 01 Jul 2020 00:00:00 EDT

Updated Date: Wed, 01 Jul 2020 00:00:00 EDT